- Home
- SMX vs NCNA Comparison
SMX vs NCNA Comparison
Compare SMX & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- NCNA
- Stock Information
- Founded
- SMX N/A
- NCNA 1997
- Country
- SMX Ireland
- NCNA United Kingdom
- Employees
- SMX N/A
- NCNA N/A
- Industry
- SMX Industrial Machinery/Components
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- SMX Technology
- NCNA Health Care
- Exchange
- SMX Nasdaq
- NCNA Nasdaq
- Market Cap
- SMX 4.8M
- NCNA 4.5M
- IPO Year
- SMX N/A
- NCNA 2017
- Fundamental
- Price
- SMX $3.08
- NCNA $1.00
- Analyst Decision
- SMX
- NCNA Buy
- Analyst Count
- SMX 0
- NCNA 2
- Target Price
- SMX N/A
- NCNA $25.00
- AVG Volume (30 Days)
- SMX 635.1K
- NCNA 87.1K
- Earning Date
- SMX 12-27-2024
- NCNA 03-19-2025
- Dividend Yield
- SMX N/A
- NCNA N/A
- EPS Growth
- SMX N/A
- NCNA N/A
- EPS
- SMX N/A
- NCNA N/A
- Revenue
- SMX N/A
- NCNA N/A
- Revenue This Year
- SMX N/A
- NCNA N/A
- Revenue Next Year
- SMX N/A
- NCNA N/A
- P/E Ratio
- SMX $0.69
- NCNA N/A
- Revenue Growth
- SMX N/A
- NCNA N/A
- 52 Week Low
- SMX $2.85
- NCNA $0.85
- 52 Week High
- SMX $1,320.00
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- SMX 36.90
- NCNA 33.85
- Support Level
- SMX $3.00
- NCNA $0.85
- Resistance Level
- SMX $4.75
- NCNA $1.10
- Average True Range (ATR)
- SMX 0.72
- NCNA 0.09
- MACD
- SMX -0.01
- NCNA -0.01
- Stochastic Oscillator
- SMX 0.57
- NCNA 35.29
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.